IPO
LOGIN
OPEN A DEMAT ACCOUNT
IPO
Login
Open a
Demat
Account
HOME
ABOUT US
PRODUCTS
Equity
Currency
Commodity
IPO
Mutual Funds
PMS
SLBM
SERVICES
Investment Banking
Institutional Equities
Wealth Management
Depository
TRADE WITH SYSTEMATIX
Partner With Us
Trading Simplified
Payment Gateway
Link UPI
KYC Updation
ReKYC
(Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
Bank Details
Account Opening Process
Incapacitated investor
RESEARCH
MARKETS
Overview
Equity
Derivatives
IPO
Mutual Funds
Commodity
Currency
Company Info
INVESTORS
Investor Login
Investor Relations
Investor Grievances
ODR
Scores
Downloads
Investor Charter
Information to Physical Shareholders
Procedure for Filing a Complaint
Investor Education
CONTACT US
Our Reach
Careers
OPEN A DEMAT ACCOUNT
HOME
ABOUT US
PRODUCTS
EQUITY
CURRENCY
COMMODITY
IPO
MUTUAL FUND
PMS
SLBM
SERVICES
INVESTMENT BANKING
INSTITUTIONAL EQUITIES
WEALTH MANAGEMENT
DEPOSITORY
TRADE WITH SYSTEMATIX
PARTNER WITH US
TRADING SIMPLIFIED
PAYMENT GATEWAY
LINK UPI
KYC UPDATION
ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
BANK DETAILS
ACCOUNT OPENING PROCESS
Incapacitated investor
RESEARCH
MARKETS
OVERVIEW
EQUITY
DERIVATIVES
IPO
MUTUAL FUND
COMMODITY
CURRENCY
COMPANY INFO
INVESTORS
INVESTOR LOGIN
INVESTOR RELATIONS
INVESTOR GRIEVANCES
ODR
SCORES
DOWNLOADS
INVESTOR CHARTER
INFORMATION TO PHYSICAL SHAREHOLDERS
PROCEDURE FOR FILING A COMPLAINT
Investor Education
CONTACT US
OUR REACH
CAREERS
Equity
Derivatives
Currency
Mutual Fund
IPO Analysis
Daily Market Tracker
Gainers & Losers
Value & Volume Toppers
52 Week Highs & Lows
New Highs & Lows
Buyers & Sellers
Out/Under Performers
Bulk Deals
Block Deals
Unusual Volume
Rising Volume
Exchange Holidays
5 Days Up & Down
Index Movers
Index Overview
Top Sectors
News & Analysis
Pre Session Commentary
Mid Session Commentary
End Session Commentary
Quick Review
Market Beat
Stock Alert
Hot Pursuit
Foreign Markets
Economy News
Corporate News
Corporate Results
Other Markets
Futures Markets
Corporate Information
Company Snapshot
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Previous Quarter Comp
Director's Report
Score Board
Mutual Fund Holdings
Announcements
Peer Comparison
Technical Chart
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Name Change
Split Of Face Value
Event Calendar
Other Markets
ADR Prices
FII Investments
MF Investments
Forex Details
World Indices
GDR Prices
Equity
Derivative
Currency
Commodity
Mutual Fund
IPO
Price Analysis
Volume Analysis
News Analysis
Market Option
Other Option
Company Information
Gainers & Losers
52 Week High Low
News Highs and Low
Advances & Declines
Home
Market Info
Corporate Information
Company Snapshot
Company Snapshot
BSE
Anthem Biosciences Ltd
BSE Code
544449
ISIN Demat
INE0CZ201020
Book Value (₹)
50.81
NSE Symbol
ANTHEM
Div & Yield %
0
Market Cap (
₹
Cr.)
35,519.03
P/E *
59.44
EPS *
10.64
Face Value (₹)
2
* Profit to Earning Ratio
* Earning Per Share
Stock Price Details
Last Price (₹)
631.15
Change
-5.40 (-0.85%)
Best Buy (₹)
0.00
Best Sell (₹)
0.00
Today's Range
620.05 - 633.15
52-Week Range
620.05 - 873.25
Beta (1 Year)
1.44
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Corporate Announcements
Anthem Biosciences consolidated net profit rises 7.10% in the September 2025 quarter
Anthem Biosciences to announce Quarterly Result
Anthem Biosciences Ltd - Anthem Biosciences Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018 :
Anthem Biosciences Ltd - Anthem Biosciences Limited - Trading Window
Anthem Biosciences Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Anthem Biosciences Ltd - Anthem Biosciences Limited - Shareholders meeting
Anthem Biosciences Ltd - Anthem Biosciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Anthem Biosciences Ltd - Anthem Biosciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Anthem Biosciences consolidated net profit rises 64.83% in the June 2025 quarter
Anthem Biosciences Ltd - Anthem Biosciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Corporate Details
Incorporation Year :
2006
Chairman :
Ajay Bhardwaj
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office :
Anthem Biosciences Ltd
49 F1 & F2 Canara Bank Road,
Bommasandra Industrial Area,
Bangalore,
Karnataka - 560099,
Phone : +91 080 6672 4000,
Fax : N.A.
E-Mail :
investors.abl@anthembio.com
URL :
http://www.anthembio.com
Investor Returns
Period
Date
Price
Returns (%)
1Week
20-Nov-2025
647.80
-3.20
1Month
27-Oct-2025
732.85
-14.44
3Month
28-Aug-2025
817.30
-23.28
6Month
21-Jul-2025
730.35
-14.14
1Year
NA
NA
NA
Mutual Funds Holding
Scheme Name
% Holding
Market Value
Quant Small Cap Fund
0.86
261.52
Kotak Small Cap Fund
0.98
177.26
HSBC Midcap Fund
1.21
149.94
Quant Mid Cap Fund
1.40
119.54
SBI MNC Fund
1.91
113.62
Peerset : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company
Last Price (₹)
Change (%)
52Week High (₹)
52Week Low (₹)
Market Cap (₹ Cr.)
Sun Pharmaceutical Industries Ltd
1,809.50
0.26
1,910.00
1,547.25
434,159.66
Cipla Ltd
1,524.55
0.07
1,672.20
1,310.05
123,148.76
Dr Reddys Laboratories Ltd
1,250.50
0.17
1,404.60
1,025.90
104,369.38
Lupin Ltd
2,072.40
0.04
2,403.45
1,774.00
94,659.39
Zydus Lifesciences Ltd
937.25
-0.34
1,059.00
797.05
94,309.28
Index Details
BSE IPO